{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:35:04Z","timestamp":1787009704051,"version":"build-2736575974"},"reference-count":72,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:00:00Z","timestamp":1713398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["178188"],"award-info":[{"award-number":["178188"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Nevirapine, an antiretroviral used in the treatment of HIV, is associated with idiosyncratic drug-induced liver injury (IDILI), a potentially life-threatening adverse drug reaction. Its usage has decreased due to this concern, but it is still widely used in lower-resource settings. In general, the mechanisms underlying idiosyncratic drug reactions (IDRs) are poorly understood, but evidence indicates that most are immune-mediated. There is very limited understanding of the early immune response following administration of drugs associated with IDRs, which likely occurs due to reactive metabolite formation. In this work, we aimed to characterize the links between covalent binding of nevirapine, the development of an early immune response, and the subsequent liver injury using a mouse model. We describe initial attempts to characterize an early immune response to nevirapine followed by the discovery that nevirapine induced the release of corticosterone. Corticosterone release was partially associated with the degree of drug covalent binding in the liver but was also likely mediated by additional mechanisms at higher drug doses. Transcriptomic analysis confirmed metabolic activation, glucocorticoid signaling, and decreased immune activation; GDF-15 also warrants further investigation as part of the immune response to nevirapine. Finally, glucocorticoid blockade preceding the first dose of nevirapine attenuated nevirapine-induced liver injury at 3\u2009weeks, suggesting that acute glucocorticoid signaling is harmful in the context of nevirapine-induced liver injury. This work demonstrates that nevirapine induces acute corticosterone release, which contributes to delayed-onset liver injury. It also has implications for screening drug candidates for IDILI risk and preventing nevirapine-induced IDILI.<\/jats:p>","DOI":"10.1093\/toxsci\/kfae054","type":"journal-article","created":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T18:25:30Z","timestamp":1713464730000},"page":"146-164","source":"Crossref","is-referenced-by-count":6,"title":["The role of corticosterone in nevirapine-induced idiosyncratic drug-induced liver injury"],"prefix":"10.1093","volume":"200","author":[{"given":"Alison","family":"Jee","sequence":"first","affiliation":[{"name":"Department of Pharmacology & Toxicology, Temerty Faculty of Medicine, University of Toronto , Toronto, ON M5S 3M2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0904-8516","authenticated-orcid":false,"given":"Samantha Christine","family":"Sernoskie","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto , Toronto, ON M5S 3M2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Uetrecht","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Toxicology, Temerty Faculty of Medicine, University of Toronto , Toronto, ON M5S 3M2, Canada"},{"name":"Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto , Toronto, ON M5S 3M2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,4,18]]},"reference":[{"key":"2024062607525225600_kfae054-B1","doi-asserted-by":"crossref","first-page":"490842","DOI":"10.1155\/2015\/490842","article-title":"GDF-15 as a target and biomarker for diabetes and cardiovascular diseases: A translational prospective","volume":"2015","author":"Adela","year":"2015","journal-title":"J. Diabetes Res"},{"key":"2024062607525225600_kfae054-B2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq-a python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"key":"2024062607525225600_kfae054-B3","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1097\/00002030-200108170-00018","article-title":"Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapy","volume":"15","author":"Antinori","year":"2001","journal-title":"AIDS"},{"key":"2024062607525225600_kfae054-B4","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1097\/00002030-200009290-00012","article-title":"Prevention of nevirapine-associated exanthema using slow dose escalation and\/or corticosteroids","volume":"14","author":"Barreiro","year":"2000","journal-title":"AIDS"},{"key":"2024062607525225600_kfae054-B5","first-page":"932542","article-title":"The role of the immune system in nevirapine-induced subclinical liver injury of a rat model","volume":"2012","author":"Bekker","year":"2012","journal-title":"ISRN Pharm"},{"key":"2024062607525225600_kfae054-B6","doi-asserted-by":"crossref","first-page":"11514","DOI":"10.1073\/pnas.94.21.11514","article-title":"MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-\u03b2\u2009superfamily","volume":"94","author":"Bootcov","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2024062607525225600_kfae054-B7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tox.2012.06.013","article-title":"Evidence for nevirapine bioactivation in man: Searching for the first step in the mechanism of nevirapine toxicity","volume":"301","author":"Caixas","year":"2012","journal-title":"Toxicology"},{"key":"2024062607525225600_kfae054-B8","first-page":"1152","article-title":"Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population","volume":"72","author":"Carr","year":"2017","journal-title":"J. Antimicrob. Chemother"},{"key":"2024062607525225600_kfae054-B9","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1128\/AAC.00486-13","article-title":"Induction of P-glycoprotein by antiretroviral drugs in human brain microvessel endothelial cells","volume":"57","author":"Chan","year":"2013","journal-title":"Antimicrob. Agents Chemother"},{"key":"2024062607525225600_kfae054-B10","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1021\/tx800177k","article-title":"Demonstration of the metabolic pathway responsible for nevirapine-induced skin rash","volume":"21","author":"Chen","year":"2008","journal-title":"Chem. Res. Toxicol"},{"key":"2024062607525225600_kfae054-B11","first-page":"e59016","article-title":"Primary culture of rat adrenocortical cells and assays of steroidogenic functions","volume":"2019","author":"Chen","year":"2019","journal-title":"J. Vis. Exp"},{"key":"2024062607525225600_kfae054-B12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1677\/jme.0.0320257","article-title":"Expressions of hepatic genes, especially IGF-binding protein-1, correlating with serum corticosterone in microarray analysis","volume":"32","author":"Cheng","year":"2004","journal-title":"J. Mol. Endocrinol"},{"key":"2024062607525225600_kfae054-B13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1021\/acs.chemrestox.6b00357","article-title":"How reactive metabolites induce an immune response that sometimes leads to an idiosyncratic drug reaction","volume":"30","author":"Cho","year":"2017","journal-title":"Chem. Res. Toxicol"},{"key":"2024062607525225600_kfae054-B14","doi-asserted-by":"crossref","first-page":"5830","DOI":"10.3390\/ijms16035830","article-title":"A pharmacogenetics study in mozambican patients treated with nevirapine: Full resequencing of TRAF3IP2 gene shows a novel association with SJS\/TEN susceptibility","volume":"16","author":"Ciccacci","year":"2015","journal-title":"Int. J. Mol. Sci"},{"key":"2024062607525225600_kfae054-B15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2217\/pgs.09.142","article-title":"Nevirapine-induced hepatotoxicity and pharmacogenetics: A retrospective study in a population from Mozambique","volume":"11","author":"Ciccacci","year":"2010","journal-title":"Pharmacogenomics"},{"key":"2024062607525225600_kfae054-B16","doi-asserted-by":"crossref","first-page":"e2106868118","DOI":"10.1073\/pnas.2106868118","article-title":"Activation of the hypothalamic-pituitary-adrenal axis by exogenous and endogenous GDF15","volume":"118","author":"Cimino","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"2024062607525225600_kfae054-B17","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/FPC.0000000000000124","article-title":"HLA-allelotype associations with nevirapine-induced hypersensitivity reactions and hepatotoxicity: A systematic review of the literature and meta-analysis","volume":"25","author":"Cornejo Castro","year":"2015","journal-title":"Pharmacogenet. Genomics"},{"key":"2024062607525225600_kfae054-B18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.antiviral.2011.04.018","article-title":"Effects of nevirapine and efavirenz on human adipocyte differentiation, gene expression, and release of adipokines and cytokines","volume":"91","author":"D\u00edaz-Delf\u00edn","year":"2011","journal-title":"Antiviral Res"},{"key":"2024062607525225600_kfae054-B19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: Ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"2024062607525225600_kfae054-B20","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/QAD.0b013e328351a521","article-title":"Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African women","volume":"26","author":"Dong","year":"2012","journal-title":"AIDS"},{"key":"2024062607525225600_kfae054-B21","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1124\/jpet.106.112136","article-title":"Relative activation of human pregnane X receptor versus constitutive androstane receptor defines distinct classes of CYP2B6 and CYP3A4 inducers","volume":"320","author":"Faucette","year":"2007","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"2024062607525225600_kfae054-B22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/ACI.0000000000000078","article-title":"The importance of hapten\u2013protein complex formation in the development of drug allergy","volume":"14","author":"Faulkner","year":"2014","journal-title":"Curr. Opin. Allergy Clin. Immunol"},{"key":"2024062607525225600_kfae054-B23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/009286150103500134","article-title":"Evaluation of the characteristics of safety withdrawal of prescription drugs from worldwide pharmaceutical markets-1960 to 1999","volume":"35","author":"Fung","year":"2001","journal-title":"Drug Information J"},{"key":"2024062607525225600_kfae054-B24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/1573403X12666160111125304","article-title":"GDF 15: A novel biomarker in the offing for heart failure","volume":"12","author":"George","year":"2016","journal-title":"Curr. Cardiol. Rev"},{"key":"2024062607525225600_kfae054-B25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-018-3462-5","article-title":"Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy","volume":"18","author":"Giacomelli","year":"2018","journal-title":"BMC Infect. Dis"},{"key":"2024062607525225600_kfae054-B26","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1210\/en.2013-1473","article-title":"Analysis of glucocorticoid receptors and their apoptotic response to dexamethasone in male murine B cells during development","volume":"155","author":"Gruver-Yates","year":"2014","journal-title":"Endocrinology"},{"key":"2024062607525225600_kfae054-B27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/imt2.43","article-title":"Complex heatmap visualization","volume":"1","author":"Gu","year":"2022","journal-title":"iMeta"},{"key":"2024062607525225600_kfae054-B28","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1086\/507097","article-title":"Pharmacogenetics of nevirapine-associated hepatotoxicity: An adult AIDS Clinical Trials Group collaboration","volume":"43","author":"Haas","year":"2006","journal-title":"Clin. Infect. Dis"},{"key":"2024062607525225600_kfae054-B29","first-page":"791","article-title":"Mechanism-based inactivation of cytochrome P-450-3A4 by mifepristone (RU486)","volume":"288","author":"He","year":"1999","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"2024062607525225600_kfae054-B30","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0167-4781(97)00122-X","article-title":"PLAB, a novel placental bone morphogenetic protein","volume":"1354","author":"Hromas","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"key":"2024062607525225600_kfae054-B31","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.3390\/ijms22062954","article-title":"Idiosyncratic drug-induced liver injury: Mechanistic and clinical challenges","volume":"22","author":"Jee","year":"2021","journal-title":"Int. J. Mol. Sci"},{"key":"2024062607525225600_kfae054-B32","volume-title":"38th Interscience Conference on Antimicrobial Agents and Chemotherapy","author":"Kaspar","year":"1998"},{"key":"2024062607525225600_kfae054-B33","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00042560-200109010-00003","article-title":"Failure of a short-term prednisone regimen to prevent nevirapine-associated rash: A double-blind placebo-controlled trial: The GESIDA 09\/99 study","volume":"28","author":"Knobel","year":"2001","journal-title":"J. Acquir. Immune Defic. Syndr"},{"key":"2024062607525225600_kfae054-B34","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1097\/QAD.0b013e3282ba553a","article-title":"African infants\u2019 CCL3 gene copies influence perinatal HIV transmission in the absence of maternal nevirapine","volume":"21","author":"Kuhn","year":"2007","journal-title":"AIDS"},{"key":"2024062607525225600_kfae054-B35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0378-1119(97)00485-X","article-title":"Identification of a novel member of the TGF-beta superfamily highly expressed in human placenta","volume":"203","author":"Lawton","year":"1997","journal-title":"Gene"},{"key":"2024062607525225600_kfae054-B36","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3181\/00379727-216-44182","article-title":"Insulin-like growth factor binding protein-1: Recent findings and new directions","volume":"216","author":"Lee","year":"1997","journal-title":"Proc. Soc. Exp. Biol. Med"},{"key":"2024062607525225600_kfae054-B37","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3181\/00379727-204-43630","article-title":"Regulation and function of insulin-like growth factor-binding protein-1","volume":"204","author":"Lee","year":"1993","journal-title":"Proc. Soc. Exp. Biol. Med"},{"key":"2024062607525225600_kfae054-B38","author":"LiverTox","year":"2012"},{"key":"2024062607525225600_kfae054-B39","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"2024062607525225600_kfae054-B40","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.cell.2019.07.033","article-title":"GDF15 is an inflammation-induced central mediator of tissue tolerance","volume":"178","author":"Luan","year":"2019","journal-title":"Cell"},{"key":"2024062607525225600_kfae054-B41","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1021\/acs.chemrestox.5b00305","article-title":"The combination of anti-CTLA-4 and PD1-\/- mice unmasks the potential of isoniazid and nevirapine to cause liver injury","volume":"28","author":"Mak","year":"2015","journal-title":"Chem. Res. Toxicol"},{"key":"2024062607525225600_kfae054-B42","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1310\/N4VT-3E9U-4BKN-CRPW","article-title":"Incidence of liver injury after beginning antiretroviral therapy with efavirenz or nevirapine","volume":"4","author":"Mart\u00edn-Carbonero","year":"2003","journal-title":"HIV Clin. Trials"},{"key":"2024062607525225600_kfae054-B43","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/00002030-200107060-00007","article-title":"Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy","volume":"15","author":"Mart\u00ednez","year":"2001","journal-title":"AIDS"},{"key":"2024062607525225600_kfae054-B44","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1021\/tx060190c","article-title":"Lymphocyte loss and immunosuppression following acetaminophen-induced hepatotoxicity in mice as a potential mechanism of tolerance","volume":"20","author":"Masson","year":"2007","journal-title":"Chem. Res. Toxicol"},{"key":"2024062607525225600_kfae054-B45","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.bbrc.2010.05.126","article-title":"Pathologic role of stressed-induced glucocorticoids in drug-induced liver injury in mice","volume":"397","author":"Masson","year":"2010","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"2024062607525225600_kfae054-B46","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1021\/tx4000107","article-title":"Detection of drug bioactivation in vivo: Mechanism of nevirapine-albumin conjugate formation in patients","volume":"26","author":"Meng","year":"2013","journal-title":"Chem. Res. Toxicol"},{"key":"2024062607525225600_kfae054-B47","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.2174\/1381612822666161003115103","article-title":"Immunological mechanisms of drug hypersensitivity","volume":"22","author":"Meng","year":"2016","journal-title":"Curr. Pharm. Des"},{"key":"2024062607525225600_kfae054-B48","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00126334-200305010-00007","article-title":"Randomized, controlled study of the effects of a short course of prednisone on the incidence of rash associated with nevirapine in patients infected with HIV-1","volume":"33","author":"Montaner","year":"2003","journal-title":"J. Acquir. Immune Defic. Syndr"},{"key":"2024062607525225600_kfae054-B49","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12916-016-0553-2","article-title":"Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: A systematic review of the world literature","volume":"14","author":"Onakpoya","year":"2016","journal-title":"BMC Med"},{"key":"2024062607525225600_kfae054-B50","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00126334-200402010-00003","article-title":"Serious adverse cutaneous and hepatic toxicities associated with nevirapine use by non-HIV-infected individuals","volume":"35","author":"Patel","year":"2004","journal-title":"J. Acquir. Immune Defic. Syndr"},{"key":"2024062607525225600_kfae054-B51","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1021\/tx0601152","article-title":"Study of the sequence of events involved in nevirapine-induced skin rash in brown Norway rats","volume":"19","author":"Popovic","year":"2006","journal-title":"Chem. Res. Toxicol"},{"key":"2024062607525225600_kfae054-B52","doi-asserted-by":"crossref","first-page":"W191","DOI":"10.1093\/nar\/gkz369","article-title":"G:Profiler: A web server for functional enrichment analysis and conversions of gene lists (2019 update)","volume":"47","author":"Raudvere","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2024062607525225600_kfae054-B53","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1097\/00002030-199911120-00016","article-title":"Prednisolone does not prevent the occurrence of nevirapine-induced rashes","volume":"13","author":"Rey","year":"1999","journal-title":"AIDS"},{"key":"2024062607525225600_kfae054-B54","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1086\/507101","article-title":"Drug transporter and metabolizing enzyme gene variants and nonnucleoside reverse-transcriptase inhibitor hepatotoxicity","volume":"43","author":"Ritchie","year":"2006","journal-title":"Clin. Infect. Dis"},{"key":"2024062607525225600_kfae054-B55","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1158\/1078-0432.CCR-10-0705","article-title":"GDF-15 contributes to proliferation and immune escape of malignant gliomas","volume":"16","author":"Roth","year":"2010","journal-title":"Clin. Cancer Res"},{"key":"2024062607525225600_kfae054-B56","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1152\/physrev.1990.70.3.591","article-title":"Insulin-like growth factors and their binding proteins","volume":"70","author":"Sara","year":"1990","journal-title":"Physiol. Rev"},{"key":"2024062607525225600_kfae054-B57","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2174\/1874613601004010156","article-title":"Effect of maternal HIV-1 status and antiretroviral drugs on haematological profiles of South African infants in early life","volume":"4","author":"Schramm","year":"2010","journal-title":"Open AIDS J"},{"key":"2024062607525225600_kfae054-B58","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1124\/pharmrev.120.000090","article-title":"The emerging role of the innate immune response in idiosyncratic drug reactions","volume":"73","author":"Sernoskie","year":"2021","journal-title":"Pharmacol. Rev"},{"key":"2024062607525225600_kfae054-B59","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1089\/aid.2008.0286","article-title":"Single-dose nevirapine exposure affects T cell response and cytokine levels in HIV type 1-infected women","volume":"25","author":"Shalekoff","year":"2009","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"2024062607525225600_kfae054-B60","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1021\/tx400098z","article-title":"12-OH-Nevirapine sulfate, formed in the skin, is responsible for nevirapine-induced skin rash","volume":"26","author":"Sharma","year":"2013","journal-title":"Chem. Res. Toxicol"},{"key":"2024062607525225600_kfae054-B61","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1021\/tx300172s","article-title":"Bioactivation of nevirapine to a reactive quinone methide: Implications for liver injury","volume":"25","author":"Sharma","year":"2012","journal-title":"Chem. Res. Toxicol"},{"key":"2024062607525225600_kfae054-B62","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/bph.12997","article-title":"Differential activation of human constitutive androstane receptor and its SV23 and SV24 splice variants by rilpivirine and etravirine","volume":"172","author":"Sharma","year":"2015","journal-title":"Br. J. Pharmacol"},{"key":"2024062607525225600_kfae054-B63","doi-asserted-by":"crossref","first-page":"102","DOI":"10.5858\/2003-127-102-TDMIHI","article-title":"Therapeutic drug monitoring in human immunodeficiency virus\/acquired immunodeficiency syndrome: Quo vadis?","volume":"127","author":"Soldin","year":"2003","journal-title":"Arch. Pathol. Lab. Med"},{"key":"2024062607525225600_kfae054-B64","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cbi.2015.11.023","article-title":"Transcriptional profiling suggests that nevirapine and ritonavir cause drug induced liver injury through distinct mechanisms in primary human hepatocytes","volume":"255","author":"Terelius","year":"2016","journal-title":"Chem. Biol. Interact"},{"key":"2024062607525225600_kfae054-B65","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.2165\/00002018-200730120-00008","article-title":"Analysis of severe hepatic events associated with nevirapine-containing regimens: CD4+ T-cell count and gender in hepatitis C seropositive and seronegative patients","volume":"30","author":"Torti","year":"2007","journal-title":"Drug Saf"},{"key":"2024062607525225600_kfae054-B66","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2018.03.025","article-title":"GDF-15, galectin 3, soluble ST2, and risk of mortality and cardiovascular events in CKD","volume":"72","author":"Tuegel","year":"2018","journal-title":"Am. J. Kidney Dis"},{"key":"2024062607525225600_kfae054-B67","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1021\/tx800389u","article-title":"Immune-mediated adverse drug reactions","volume":"22","author":"Uetrecht","year":"2009","journal-title":"Chem. Res. Toxicol"},{"key":"2024062607525225600_kfae054-B68","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/01.aids.0000162334.12815.5b","article-title":"The effect of baseline CD4 cell count and HIV-1 viral load on the efficacy and safety of nevirapine or efavirenz-based first-line HAART","volume":"19","author":"van Leth","year":"2005","journal-title":"AIDS"},{"key":"2024062607525225600_kfae054-B69","author":"Viramune (nevirapine) product monograph","year":"2005"},{"key":"2024062607525225600_kfae054-B70","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/mgme.1999.2920","article-title":"Novel aspects of the insulin-like growth factor binding proteins","volume":"68","author":"Wetterau","year":"1999","journal-title":"Mol. Genet. Metab"},{"key":"2024062607525225600_kfae054-B71","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3389\/fimmu.2020.00951","article-title":"Growth\/differentiation factor-15 (GDF-15): From biomarker to novel targetable immune checkpoint","volume":"11","author":"Wischhusen","year":"2020","journal-title":"Front. Immunol"},{"key":"2024062607525225600_kfae054-B72","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1097\/00002030-200112070-00010","article-title":"Prednisolone does not prevent hypersensitivity reactions in antiretroviral drug regimens containing abacavir with or without nevirapine","volume":"15","author":"Wit","year":"2001","journal-title":"AIDS"}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/toxsci\/advance-article-pdf\/doi\/10.1093\/toxsci\/kfae054\/57436125\/kfae054.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/toxsci\/article-pdf\/200\/1\/146\/58318792\/kfae054.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/toxsci\/article-pdf\/200\/1\/146\/58318792\/kfae054.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T03:58:37Z","timestamp":1719374317000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/toxsci\/article\/200\/1\/146\/7651213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,18]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,4,18]]},"published-print":{"date-parts":[[2024,6,26]]}},"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kfae054","relation":{},"ISSN":["1096-6080","1096-0929"],"issn-type":[{"value":"1096-6080","type":"print"},{"value":"1096-0929","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2024,4,18]]}}}